CAN
AUPH icon

Cetera Advisor Networks’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cetera Advisor Networks’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,279
Closed -$92.4K – 2817
2023
Q4 		$92.4K Hold
10,279
– – ﹤0.01% 2652
2023
Q3 		$79.9K Sell
10,279
-743
-7% -$7.27K ﹤0.01% 2596
2023
Q2 		$107K Hold
11,022
– – ﹤0.01% 2457
2023
Q1 		$121K Hold
11,022
– – ﹤0.01% 2414
2022
Q4 		$47.6K Hold
11,022
– – ﹤0.01% 2447
2022
Q3 		$83K Buy
+11,022
New +$95.4K ﹤0.01% 1981
2022
Q1 		– Sell
-9,611
Closed -$220K – 2072
2021
Q4 		$220K Buy
+9,611
New +$228K ﹤0.01% 1812
2020
Q3 		– Sell
-920
Closed -$15K – 1348
2020
Q2 		$15K Buy
+920
New +$14.7K ﹤0.01% 2534

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cetera Advisor Networks's AUPH Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 10,279 shares — an estimated $92.4K sold.

Cetera Advisor Networks first reported a position in AUPH in Q2 2020 and held it in 8 quarters. The position peaked at $220K in Q4 2021. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Cetera Advisor Networks reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 10,279 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $92.4K.
  • Cetera Advisor Networks first reported a position in Aurinia Pharmaceuticals in Q2 2020 and held it in 8 quarters.
  • Cetera Advisor Networks's Aurinia Pharmaceuticals position peaked at $220K in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.